Jpmorgan Chase & CO Revolution Medicines, Inc. Transaction History

Jpmorgan Chase & CO

$1.51 Trillion
Q3 2025

A detailed history of Jpmorgan Chase & CO transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 2,498,327 shares of RVMD stock, worth $160 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,498,327

Previous 3,702,909 32.53%

Holding current value

$160 Million

Previous $131 Million 10.89%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 07, 2025	SELL	$34.7 - $46.7 $41.8 Million - $56.3 Million	-1,204,582 Reduced 32.53%	2,498,327 $117 Million
Q1 2025 May 12, 2025	SELL	$35.36 - $44.42 $4.47 Million - $5.62 Million	-126,440 Reduced 3.3%	3,702,909 $131 Million
Q4 2024 Feb 12, 2025	SELL	$42.97 - $60.6 $13.3 Million - $18.7 Million	-308,571 Reduced 7.46%	3,829,349 $167 Million
Q3 2024 Dec 26, 2024	BUY	$36.92 - $47.94 $37.7 Million - $49 Million	1,022,345 Added 32.81%	4,137,920 $187 Million
Q3 2024 Nov 08, 2024	BUY	$36.92 - $47.94 $37.7 Million - $49 Million	1,022,345 Added 32.81%	4,137,920 $187 Million
Q2 2024 Dec 26, 2024	SELL	$30.14 - $40.68 $30.8 Million - $41.6 Million	-1,022,345 Reduced 24.71%	3,115,575 $121 Million
Q2 2024 Aug 12, 2024	SELL	$30.14 - $40.68 $11.9 Million - $16 Million	-393,529 Reduced 11.21%	3,115,575 $121 Million
Q1 2024 Dec 26, 2024	SELL	$26.56 - $33.55 $16.7 Million - $21.1 Million	-628,816 Reduced 15.2%	3,509,104 $113 Million
Q1 2024 May 10, 2024	SELL	$26.56 - $33.55 $23.4 Million - $29.6 Million	-882,525 Reduced 20.1%	3,509,104 $113 Million
Q4 2023 Dec 26, 2024	BUY	$18.35 - $34.12 $4.66 Million - $8.66 Million	253,709 Added 6.13%	4,391,629 $126 Million
Q4 2023 Feb 12, 2024	BUY	$18.35 - $34.12 $2.05 Million - $3.81 Million	111,710 Added 2.61%	4,391,629 $126 Million
Q3 2023 Nov 14, 2023	BUY	$25.17 - $35.05 $7.86 Million - $10.9 Million	312,166 Added 7.87%	4,279,919 $118 Million
Q2 2023 Aug 11, 2023	BUY	$20.28 - $27.0 $14.3 Million - $19 Million	705,115 Added 21.61%	3,967,753 $106 Million
Q1 2023 May 18, 2023	BUY	$20.76 - $30.09 $2.29 Million - $3.32 Million	110,265 Added 3.5%	3,262,638 $70.7 Million
Q1 2023 May 11, 2023	BUY	$20.76 - $30.09 $11.5 Million - $16.7 Million	556,319 Added 21.43%	3,152,373 $68.3 Million
Q4 2022 Feb 13, 2023	BUY	$17.68 - $25.53 $14.2 Million - $20.5 Million	804,606 Added 44.91%	2,596,054 $61.8 Million
Q3 2022 Nov 14, 2022	SELL	$17.46 - $26.0 $1.07 Million - $1.6 Million	-61,404 Reduced 3.31%	1,791,448 $35.3 Million
Q2 2022 Aug 11, 2022	BUY	$14.54 - $27.17 $7.45 Million - $13.9 Million	512,237 Added 38.21%	1,852,852 $36.1 Million
Q1 2022 May 11, 2022	BUY	$17.31 - $26.4 $1.02 Million - $1.56 Million	58,914 Added 4.6%	1,340,615 $34.2 Million
Q4 2021 Feb 10, 2022	SELL	$24.35 - $33.7 $899,562 - $1.24 Million	-36,943 Reduced 2.8%	1,281,701 $32.3 Million
Q3 2021 Nov 12, 2021	BUY	$23.95 - $33.41 $31.6 Million - $44.1 Million	1,318,644 New	1,318,644 $36.3 Million

Others Institutions Holding RVMD

# of Institutions

340

Shares Held

193M

Call Options Held

878K

Put Options Held

693K

View Full List

About Revolution Medicines, Inc.

Ticker RVMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,697,600
Market Cap $5.62B
Description
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...

More about RVMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Revolution Medicines, Inc. Transaction History